Literature DB >> 326579

Inhibition of serotonin reuptake.

R W Fuller, D T Wong.   

Abstract

An uptake system on the serotonin neuronal membrane apparently functions to inactivate serotonin that has been released into the synaptic cleft. Various inhibitors of this active transport system on serotonin neurons are known, and some are specific in the sense that they do not inhibit the active uptake system on norepinephrine neurons. The most widely studied specific inhibitor of the serotonin neuron pump is fluoxetine, 3-(p-trifluoromethylphenoxy-N-methyl-3-phenyl propylamine (Lilly 110140). When fluoxetine or other effective but less specific serotonin uptake inhibitors are given, a rapid decrease in serotonin turnover occurs and the rate of firing of single neural units in the serotonin rich raphe area of brain is reduced. This decrease in serotonin turnover and release may be a compensatroy mechanism in response to an enhanced action of serotonin on synaptic receptors. Through the use of fluoxetine and other serotonin uptake inhibitors, the role of serotonin neurons in various brain functions--behavior, sleep, regulation of pituitary hormone release, thermoregulation, pain responsiveness, and so on--can be studied.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326579

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  33 in total

1.  Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence.

Authors:  J McGuirk; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Delayed Antidepressant Efficacy and the Desensitization Hypothesis.

Authors:  Kathryn G Commons; Sofia E Linnros
Journal:  ACS Chem Neurosci       Date:  2019-03-11       Impact factor: 4.418

3.  Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.

Authors:  Rajapillai L I Pillai; Chuan Huang; Andrew LaBella; Mengru Zhang; Jie Yang; Madhukar Trivedi; Myrna Weissman; Patrick McGrath; Maurizio Fava; Benji Kurian; Crystal Cooper; Melvin McInnis; Maria A Oquendo; Diego A Pizzagalli; Ramin V Parsey; Christine DeLorenzo
Journal:  J Affect Disord       Date:  2019-05-28       Impact factor: 4.839

4.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Jessica Yu; Jeesun Kim; Larisa V Lysenko; Zheng Zeng; Y Eugene Yu; William C Mobley
Journal:  Neurobiol Dis       Date:  2017-03-22       Impact factor: 5.996

5.  Increased serotonin turnover in corpus striatum following an injection of kainic acid: evidence for neuronal feedback regulation of synthesis.

Authors:  L M Neckers; N H Neff; R J Wyatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

6.  Enhancement of melatonin's antigonadal action by daily injections of the serotonin uptake inhibitor fluoxetine in male hamsters.

Authors:  J M Olcese
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal.

Authors:  P J Cowen; S Fraser; D G Grahame-Smith; A R Green; C Stanford
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

Review 8.  Sexual behavior of the male schizophrenic: the impact of illness and medications.

Authors:  J N Nestoros; H E Lehmann; T A Ban
Journal:  Arch Sex Behav       Date:  1981-10

9.  Sympathetic denervation and chronic serotonin uptake blockade by fluoxetine do not affect pineal gland 5-hydroxyindole acetic acid: evidence that oxidative deamination of pineal serotonin is a property of the pinealocyte.

Authors:  J A McNulty; V Colin
Journal:  J Neural Transm Gen Sect       Date:  1992

10.  Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism.

Authors:  P D Henry; M Yokoyama
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.